Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Financials | 6.16% |
| 3 | Industrials | 5.09% |
| 4 | Consumer Discretionary | 4.89% |
| 5 | Healthcare | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Core Laboratories
CLB
$571M
| $19.4M | 0.01% |
177,096
+160,265
| +952% | +$16M |
|
1102
Red Robin
RRGB
$183M
| $19.4M | 0.01% |
343,554
+97,615
| +40% | +$5.62M |
|
1103
PUT
Becton Dickinson
BDX
$50B
| $19.4M | 0.01% |
92,763
+44,895
| +94% | +$9.4M |
|
1104
CALL
Take-Two Interactive
TTWO
$45.2B
| $19.4M | 0.01% |
176,400
+5,100
| +3% | +$557K |
|
1105
Antero Midstream
AM
$10.5B
| $19.4M | 0.01% |
981,321
+502,552
| +105% | +$9.34M |
|
1106
BlackBerry
BB
$5.27B
| $19.3M | 0.01% |
1,730,762
+1,313,306
| +315% | +$14.3M |
|
1107
CALL
Invesco CurrencyShares Euro Currency Trust
FXE
$340M
| $19.3M | 0.01% |
167,200
-158,100
| -49% | -$18M |
|
1108
PUT
MetLife
MET
$61.4B
| $19.3M | 0.01% |
382,200
+180,100
| +89% | +$9.49M |
|
1109
Pentair
PNR
$10.5B
| $19.3M | 0.01% |
407,250
+90,565
| +29% | +$4.23M |
|
|
CAVM
1110
DELISTED
Cavium, Inc.
CAVM
| $19.3M | 0.01% |
230,246
-321,577
| -58% | -$24.9M |
|
1111
PUT
Ally Financial
ALLY
$13.6B
| $19.2M | 0.01% |
658,200
+111,000
| +20% | +$2.95M |
|
1112
PUT
First Solar
FSLR
$24B
| $19.1M | 0.01% |
283,500
-149,000
| -34% | -$8.74M |
|
1113
Urban Outfitters
URBN
$6.63B
| $19.1M | 0.01% |
545,838
-1,489,613
| -73% | -$41.7M |
|
1114
PUT
Thermo Fisher Scientific
TMO
$223B
| $19M | 0.01% |
100,300
+25,000
| +33% | +$4.79M |
|
1115
Huntington Ingalls Industries
HII
$12.8B
| $19M | 0.01% |
80,549
+73,921
| +1,115% | +$17.4M |
|
1116
Molson Coors Class B
TAP
$7.85B
| $19M | 0.01% |
231,121
-42,895
| -16% | -$3.47M |
|
1117
Blackrock
BLK
$180B
| $19M | 0.01% |
36,905
-127,634
| -78% | -$62M |
|
1118
CALL
Cummins
CMI
$87B
| $19M | 0.01% |
107,300
-17,600
| -14% | -$3.01M |
|
|
K
1119
PUT
DELISTED
Kellanova
K
| $19M | 0.01% |
296,922
-18,531
| -6% | -$1.12M |
|
|
RHT
1120
CALL
DELISTED
Red Hat Inc
RHT
| $19M | 0.01% |
157,800
+43,600
| +38% | +$5.34M |
|
1121
Cigna
CI
$73.5B
| $18.9M | 0.01% |
93,212
+69,592
| +295% | +$13.9M |
|
1122
PUT
Ford
F
$55.4B
| $18.9M | 0.01% |
1,514,300
+602,800
| +66% | +$7.42M |
|
1123
PUT
PVH
PVH
$3.76B
| $18.8M | 0.01% |
136,900
+36,800
| +37% | +$4.81M |
|
1124
CALL
Herbalife
HLF
$1.28B
| $18.8M | 0.01% |
554,000
-4,200
| -0.8% | -$147K |
|
|
K
1125
DELISTED
Kellanova
K
| $18.6M | 0.01% |
291,840
-1,017,916
| -78% | -$61.3M |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.